S-23 Powder 1000mg
42,90 €
Efectos principales of S23: builds muscle mass, increases strength, stamina, fat loss and bone strength. Utilizado para bulking.
- Descripción
- Valoraciones (0)
Descripción
Descripción del Producto
This product is primarily designed to support muscle growth and development. When consumed as directed, it is said to promote increased strength and stamina, aid in fat loss, and help develop a hard muscular aesthetic. Not only does it enhance muscle mass, but it also boosts bone strength.
Efectos principales
-
Helps build muscle mass: It aids in building muscle by accelerating the rate of protein synthesis and encouraging more efficient muscle development and growth.
-
Increases strength: Regular use of this product, in combination with a suitable exercise regimen, could lead to considerable increases in strength.
-
Increases stamina: It can help enhance stamina, thereby improving workout intensity and duration.
-
Helps with fat loss: It assists in the burning of body fat by boosting metabolism.
-
Develops hard muscle aesthetic: Regular use of this product may lead to the development of hard, lean muscles.
-
Increases bone strength: The product strengthens bones by improving their density and reducing the likelihood of fractures and other related injuries.
Usado para
This product should be used primarily for bulking purposes.
Combina con
Ligandrol (LGD-4033), Cardarine (GW-501516), Andarine (S-4), and Ibutamoren (MK-677) are all proven stacks to combine with this product for the best results.
Especificaciones del producto
- Cas: 1010396-29-8
- Masa molar: 416,75 g/mol
- Fórmula: C18H13CIF4N2O3
- Pureza: 99%+
- Almacenamiento: room temperature
- Vida útil de almacenamiento: 2 years
- Sinónimos: S23
Before beginning any new supplement regimen, please consult with your healthcare provider.
Referencias científicas
| Ingrediente | Título del estudio | Autores | Año | DOI |
| — | — | — | — | — |
| S-23 | “Evaluation of acute and subchronic oral toxicity of the selective androgen receptor modulator (SARM) S-23” | Hylton Miller, Cynthia Kearbey, Uma Gubbala, Andrew Narayanan, James Fisher, Nihal Sinha, Mitchell Steiner, and James Dalton | 2021 | DOI:10.1002/jat.4117 |
| S-23 | “New Nonsteroidal Androgen
Receptor Partial Agonist” | De Leon Magana, Armando, Garrido A., Navarro M. Hernandez, Manuel, Cutino Baza, Laura, Del Prado Garcia, Marieta, & del C. Hernandez Cano, Maria | 2018 | DOI:10.1007/978-3-030-26763-5_4 |
| S-23 | “SARM S-23 Potential as a Male Hormonal Contraceptive” | Gao, William, & Fisher, James | 2019 | DOI:10.1007/978-3-030-38266-7_2 |
Valoraciones
No hay valoraciones aún.